The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ruby Qc Investment Holdings Pte Ltd
AKUMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ruby QC Investment Holdings Pte Ltd, a Singapore-based investor and not part of the promoter/promoter group, has sold its entire equity stake of 72,78,535 shares (4.6244% of Akums Drugs' share capital) through a Block Deal on December 22, 2025. Before this transaction, Ruby QC held exactly these 72,78,535 shares (4.6244%); after the disposal, its holding has fallen to zero, meaning a complete exit from the company. The transaction was executed on the NSE/BSE at face value Rs 2 per share reporting basis. Because the seller is a foreign (Singapore) entity, this represents a full FII exit from Akums Drugs. The disclosure is mandatory under SEBI's takeover regulations since the stake crossed the 5% reporting threshold threshold logic for disposals.
This is a significant foreign institutional investor exit — a Singapore-based fund has fully sold off its 4.62% stake via a block deal, which could create short-term supply pressure on the stock but also signals a clean change of hands. Retail investors should monitor post-block-deal price action and check whether any new large holder has accumulated this stake.